Merck & Co., Inc. (NYSE:MRK)

Medicine pills

Short Sellers Increase Bets in Major Pharma

The short interest data have been released for the January 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

Stocks were getting pounded on Tuesday. The selling pressure seems to not have an end in 2016, even after investors successfully bought every dip for over four years. It still ...
Read Full Story »
Prescription drugs

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them ...
Read Full Story »
Medicine pills

How Analysts View Pfizer and Merck After Earnings

Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) released their most recent earnings reports last week. As a result, analysts weighed in on both of these pharmaceutical ...
Read Full Story »
coins

Merck Trips Up Over Mixed Earnings

Merck & Co. Inc. (NYSE: MRK) reported its fourth-quarter financial results before the markets opened Wednesday. The company had $0.93 in earnings per share (EPS) on $10.21 billion in revenue, ...
Read Full Story »
Medicine pills

Top 3 Dow Earnings for the Coming Week

Earnings season for the fourth quarter of last year has now moved into February, and 24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average ...
Read Full Story »
crash

5 Dow Stocks Getting Slammed in 2016 Have Not Even Reported Earnings Yet

2016 has not seen a good start to the year for investors. There are many positives, but the negatives are still winning and caution is in the air. Only six ...
Read Full Story »
Medicine pills

Short Sellers Become More Selective on Major Pharma

The short interest data have been released for the January 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
thinkstockphotos-522646895

The 4 Stocks That Tanked the Dow on Wednesday

January 27, 2016: Markets opened lower on Wednesday, but a brief morning sojourn into positive territory only lasted until the FOMC announcement in the early after. Traders saw their shadows ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Stocks were indicated lower after companies like Apple, Boeing and AT&T were taking shareholders down after earnings. The volatility in 2016 remains in place. While investors may have seen every ...
Read Full Story »
cancer

Could This Merck Deal Be the Turning Point for Affimed?

Affimed N.V. (NASDAQ: AFMD) shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck & Co. Inc. (NYSE: MRK). Specifically, this agreement is between ...
Read Full Story »
buy sell stocks

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Investors have moved from buying every pullback, a pattern that had not been interrupted once from 2011 to 2014, to a mentality of selling each market rally. On last look, ...
Read Full Story »
Dow

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

A bull market interrupted is how many investors likely feel at the start of 2016 after the Dow Jones Industrial Average (DJIA) fell by 2.2% in 2015. Then the worst start ...
Read Full Story »
Medicine pills

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
buy now

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

This week has been brutal for investors as the markets retraced the lion's share of the gains that came off the bottom of the late summer, early fall correction. However, ...
Read Full Story »